Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.90
|
3.17
|
3.10
|
3.03
|
3.21
|
3.06
|
|
|
265 731.45
|
717.00
|
2.63
|
3.00
|
3.06
|
2.925
|
3.09
|
2.97
|
|
|
194 458.26
|
705.00
|
2.92
|
3.08
|
2.78
|
2.75
|
3.02
|
2.92
|
|
|
449 551.68
|
1 370.00
|
2.75
|
2.83
|
2.82
|
2.70
|
2.905
|
2.76
|
|
|
343 284.58
|
891.00
|
2.83
|
2.85
|
2.95
|
2.785
|
3.09
|
2.83
|
|
|
375 585.49
|
842.00
|
2.80
|
2.92
|
2.83
|
2.76
|
2.93
|
2.88
|
|
|
257 036.25
|
800.00
|
2.86
|
2.88
|
2.96
|
2.845
|
2.98
|
2.85
|
|
|
367 954.72
|
788.00
|
3.00
|
3.25
|
3.37
|
3.03
|
3.40
|
3.035
|
|
|
426 654.15
|
853.00
|
3.37
|
3.41
|
3.47
|
3.36
|
3.53
|
3.365
|
|
|
324 862.05
|
863.00
|
3.38
|
3.46
|
3.47
|
3.39
|
3.63
|
3.39
|
|
|
233 208.27
|
780.00
|
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company was founded in 2017 and is headquartered in South San Francisco, California.